Denali Therapeutics Inc. (DNLI) short interest & options flow
NASDAQDenali Therapeutics gained 1.2% over the past week while its closest biotech peers fell a median 3.9%, a gap that makes Wednesday's Q3 print the clearest near-term test of whether that relative strength holds. The most consequential shift in the data this week is not in the stock price but in what analysts did immediately after the earnings date was confirmed. Morgan Stanley's…
- Market cap
- $3.16B
- Next earnings
- 26 Feb 2027
Key data as of 12 Nov 2026

DNLI news and analysis
RSSNo long-form analysis yet for DNLI. Pulse alerts and the live data picture are available on ORTEX.
Open DNLI on ORTEX →Want the live picture for DNLI?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for DNLI — free to start on ORTEX.
Sign up for free →Open DNLI on ORTEX